Metformin
Also sold as Glucophage.
- Half-life
- 6 h
- Steady state
- ~1 d
- Class
- Insulin sensitivity
- Category
- Other
Published population averages. Steady state is the usual five half-life rule of thumb, not a measurement. See peptide half-life, explained.
Overview
Metformin is a biguanide oral antidiabetic drug and the most-prescribed diabetes medication worldwide. Beyond glucose control, it has attracted enormous interest as a potential longevity drug due to observational data showing reduced cancer incidence and mortality in diabetic patients taking metformin. The TAME (Targeting Aging with Metformin) trial aims to test this formally.
How it works
Activates AMPK (AMP-activated protein kinase) by mildly inhibiting mitochondrial complex I, shifting cellular energy sensing toward a 'fasted' state. Reduces hepatic glucose production, increases insulin sensitivity in peripheral tissues, modulates gut microbiome composition, inhibits mTORC1 (longevity pathway overlap with rapamycin), and reduces inflammation via NF-κB inhibition. May also extend lifespan by reducing oxidative stress and advanced glycation end-products.
Half-life and peak
Oral half-life approximately 5–6 hours. Peak plasma concentration reached in 2.5 hours (immediate-release) or 7 hours (extended-release). Not metabolized — excreted unchanged renally. Typical dose: 500–2000 mg/day. Extended-release preferred for GI tolerability.
What it is studied for
T2DM first-line therapy, longevity and healthspan (TAME trial), cancer prevention, PCOS, AMPK activation, mTOR modulation, cardiovascular protection.
Research status
FDA-approved for T2DM (since 1994 in US). WHO Essential Medicine. TAME trial (Targeting Aging with Metformin) designed by Nir Barzilai to test longevity effects in non-diabetic elderly — landmark study in geroscience. Decades of safety data.
Sources
- Metformin — MedlinePlus · medlineplus.gov
- TAME trial rationale — Cell Metabolism · doi.org
- Metformin and longevity — Aging Cell · doi.org
- Metformin clinical pharmacokinetics — Clinical Pharmacokinetics · doi.org
Educational reference only. This page describes what is published about a compound; it is not medical advice, not a recommendation to take anything, and not a dosing guide. Several compounds in this catalog are investigational and are not approved medicines. Talk to a doctor.